MRI can detect 90 percent of breast cancers
the ONA take:
A recent study has determined that approximately 90 percent of breast cancers can be diagnosed via magnetic resonance imaging (MRI).
The research team, based at the University Department of Radiology and Nuclear Medicine at the MedUni Vienna, in cooperation with the University Department of Gynaecology and Obstetrics and the Clinical Institute of Pathology, compared results from mammography, ultrasound, and MRI testing.
Records from 559 women with breast cancer were reviewed, which totaled 1,365 screening tests. Ultrasound alone was not useful in detecting the breast cancer, whereas MRI clearly established the presence of breast cancer approximately 90 percent of the time.
The addition of mammography screen to MRI increased detection by approximately 5 percent. Screening results for the various methods to detect benign lesions was comparable. Results were also unaffected by the variables of gene mutation, age of the patient, or degree of breast density.
Study leaders Thomas Helbich and Christopher Riedl feel the results should serve as a call for increased use of NRI for breast cancer detection, and that high-risk individuals with a family history of breast cancer should opt for yearly MRI testing.
The current EU ratio is 10 MRI scanners per one million inhabitants, a somewhat low ratio if MRI testing were to be increased.
Study findings were published in the Journal of Clinical Oncology.
A recent study has determined that approximately 90 percent of breast cancers can be diagnosed via MRI.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|